MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Barriers to exercise in newly diagnosed Parkinson’s disease

I. Argyropoulos, E. Pearson, F. Murphy, V. Queen, J. Rideout, C. Carrollq (Plymouth, United Kingdom)

Meeting: 2017 International Congress

Abstract Number: 715

Keywords: Interventions

Session Information

Date: Tuesday, June 6, 2017

Session Title: Therapy in Movement Disorders

Session Time: 1:45pm-3:15pm

Location: Exhibit Hall C

Objective: To evaluate and understand the perceived benefits and barriers towards physical activity in newly-diagnosed people with Parkinson’s disease (PwP).

Background: The evidence base to support regular physical activity in the management of Parkinson’s disease is increasing. Regular exercise and physical activity is now understood to play a key role in short-term symptom relief, as well as possibly slowing disease progression. A new patient pathway has been developed at Plymouth Hospitals NHS trust, an aspect of which entails providing patients with patient-centred information on how to become and/or remain physically active. This study aims to achieve a better understanding of the perceived benefits and barriers for patients in undertaking regular physical activity.

Methods: Two questionnaires, the 4-item Physical Activity Cycle of Change and 43-item Exercise Benefits and Barriers Survey, will be administered over the telephone to 30 newly-diagnosed PwP from 3 Parkinson’s services in Devon. The first serves to objectively assess patients’ current overall level of physical activity as well as their readiness to undertake regular exercise. The second aims to quantify patient’s attitudes towards exercise, and provide data on patients’ perceived benefits of and barriers to undertaking physical activity. Demographic data such as age, gender, time since diagnosis, and current pharmacological therapy (if any) will also be collected.

Results: This project is still in the data collection phase. Multivariate analysis of the various demographic factors, and analysis of specific responses will hopefully serve to provide insight into the overall perceptions of patients towards exercise, as well as highlight any specific perceived barriers to exercise that may be prevalent in the patient population.

Conclusions: It is expected the findings will provide evidence that certain factors influence patients’ perceptions towards exercise, and any specific barriers highlighted by the analysis could hold implications for the way in which healthcare professionals discuss exercise with newly-diagnosed patients. More tailored and patient-centred promotion of regular exercise for individual patients will hopefully result in an increase in patients’ level of physical activity, and play an important role in the effort to improve their overall health and quality of life.

To cite this abstract in AMA style:

I. Argyropoulos, E. Pearson, F. Murphy, V. Queen, J. Rideout, C. Carrollq. Barriers to exercise in newly diagnosed Parkinson’s disease [abstract]. Mov Disord. 2017; 32 (suppl 2). https://www.mdsabstracts.org/abstract/barriers-to-exercise-in-newly-diagnosed-parkinsons-disease/. Accessed May 9, 2025.
  • Tweet
  • Email
  • Print

« Back to 2017 International Congress

MDS Abstracts - https://www.mdsabstracts.org/abstract/barriers-to-exercise-in-newly-diagnosed-parkinsons-disease/

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • The hardest symptoms that bother patients with Parkinson's disease
  • The clinical effects of mucuna and green tea in combination with levodopa-benserazide in advanced Parkinson's disease: Experience from a case report
  • To be or not to bupropion: a drug-induced parkinsonism?
  • #25822 (not found)
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • The hardest symptoms that bother patients with Parkinson's disease
  • Life expectancy with and without Parkinson’s disease in the general population
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • Restless Leg Syndrome After Propranolol Intake: A Single Case
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley